Motor Imagery and Functional Performance in Diplegic Cerebral Palsy
Investigation of the Relationship Between Motor Imagery Ability and Functional Mobility, Walking, and Balance in Children With Diplegic Cerebral Palsy
Inonu University
99 participants
Nov 24, 2025
OBSERVATIONAL
Conditions
Summary
The main purpose of this study was to examine the relationship between motor imagery capacity and functional mobility, walking and balance in children with diplegic type cerebral palsy.
Eligibility
Inclusion Criteria6
- Diagnosed with diplegic CP by a neurologist or pediatric neurologist
- Being between 5 and 18 years of age
- Being between levels I and III on the GMFCS
- Having the cognitive ability to follow the assessment instructions
- Informed consent form has been obtained from the child's family
- The child has agreed to participate voluntarily in the study
Exclusion Criteria4
- Having severe impairments in basic sensory systems such as vision or hearing
- Having additional diagnoses such as epilepsy or autism spectrum disorder
- Demonstrating cognitive or behavioral problems that prevent them from following instructions during the assessment
- Having informed consent from the child's family or the child
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Laterality Task (Choice Task): Implicit Motor Imagery capacity will be measured through a laterality task, which involves deciding which side a limb belongs to. Right-left discrimination of the foot will be assessed using the "Recognize Foot" application developed by the Neuro Orthopaedic Institute
A mental stopwatch will be used to assess explicit MI capacity. This paradigm compares the time between the actual movement duration and the duration of a similar imagined task.
Functional Mobility: Functional Mobility will be assessed using the Functional Mobility Scale (FMS) and the Timed Up and Go test.
Gait assessment: The Gillette FDA is a self- or observer-based assessment tool.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07287215